These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 31629396)

  • 1. The Contribution of Formyl Peptide Receptor Dysfunction to the Course of Neuroinflammation: A Potential Role in the Brain Pathology.
    Trojan E; Bryniarska N; Leśkiewicz M; Regulska M; Chamera K; Szuster-Głuszczak M; Leopoldo M; Lacivita E; Basta-Kaim A
    Curr Neuropharmacol; 2020; 18(3):229-249. PubMed ID: 31629396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formyl peptide receptor 2, as an important target for ligands triggering the inflammatory response regulation: a link to brain pathology.
    Tylek K; Trojan E; Regulska M; Lacivita E; Leopoldo M; Basta-Kaim A
    Pharmacol Rep; 2021 Aug; 73(4):1004-1019. PubMed ID: 34105114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formyl Peptide Receptor (FPR)1 Modulation by Resveratrol in an LPS-Induced Neuroinflammatory Animal Model.
    Calvello R; Cianciulli A; Porro C; Moda P; De Nuccio F; Nicolardi G; Giannotti L; Panaro MA; Lofrumento DD
    Nutrients; 2021 Apr; 13(5):. PubMed ID: 33922475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploiting formyl peptide receptor 2 to promote microglial resolution: a new approach to Alzheimer's disease treatment.
    Wickstead ES; Irving MA; Getting SJ; McArthur S
    FEBS J; 2022 Apr; 289(7):1801-1822. PubMed ID: 33811735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of formyl peptide receptor-like 1 (FPRL1/FPR2) in mononuclear phagocyte responses in Alzheimer disease.
    Iribarren P; Zhou Y; Hu J; Le Y; Wang JM
    Immunol Res; 2005; 31(3):165-76. PubMed ID: 15888909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mast cells, glia and neuroinflammation: partners in crime?
    Skaper SD; Facci L; Giusti P
    Immunology; 2014 Mar; 141(3):314-27. PubMed ID: 24032675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formyl peptide receptor 2 as a potential therapeutic target for inflammatory bowel disease.
    Yang WS; Wang JL; Wu W; Wang GF; Yan J; Liu Q; Wu XY; Zhou QT; Yang DH; Wang MW; Li ZP
    Acta Pharmacol Sin; 2023 Jan; 44(1):19-31. PubMed ID: 35840658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotactic Ligands that Activate G-Protein-Coupled Formylpeptide Receptors.
    Krepel SA; Wang JM
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like receptors in the pathogenesis of neuroinflammation.
    Kumar V
    J Neuroimmunol; 2019 Jul; 332():16-30. PubMed ID: 30928868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptors for pro-resolving mediators are increased in Alzheimer's disease brain.
    Emre C; Hjorth E; Bharani K; Carroll S; Granholm AC; Schultzberg M
    Brain Pathol; 2020 May; 30(3):614-640. PubMed ID: 31912564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging contributions of formyl peptide receptors to neurodegenerative diseases.
    Busch L; Vieten S; Brödel S; Endres K; Bufe B
    Biol Chem; 2022 Jan; 403(1):27-41. PubMed ID: 34505459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formyl-Peptide Receptors in Infection, Inflammation, and Cancer.
    Weiß E; Kretschmer D
    Trends Immunol; 2018 Oct; 39(10):815-829. PubMed ID: 30195466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astrocytic Orosomucoid-2 Modulates Microglial Activation and Neuroinflammation.
    Jo M; Kim JH; Song GJ; Seo M; Hwang EM; Suk K
    J Neurosci; 2017 Mar; 37(11):2878-2894. PubMed ID: 28193696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Formyl Peptide Receptors in Neurological Diseases via Regulating Inflammation.
    Zhu J; Li L; Ding J; Huang J; Shao A; Tang B
    Front Cell Neurosci; 2021; 15():753832. PubMed ID: 34650406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel ureidopropanamide based N-formyl peptide receptor 2 (FPR2) agonists with potential application for central nervous system disorders characterized by neuroinflammation.
    Stama ML; Ślusarczyk J; Lacivita E; Kirpotina LN; Schepetkin IA; Chamera K; Riganti C; Perrone R; Quinn MT; Basta-Kaim A; Leopoldo M
    Eur J Med Chem; 2017 Dec; 141():703-720. PubMed ID: 29102463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formyl Peptide Receptors in Cellular Differentiation and Inflammatory Diseases.
    Lee HY; Lee M; Bae YS
    J Cell Biochem; 2017 Jun; 118(6):1300-1307. PubMed ID: 28075050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of formyl peptide receptors (FPR) in abnormal inflammation responses involved in neurodegenerative diseases.
    Mollica A; Stefanucci A; Costante R; Pinnen F
    Antiinflamm Antiallergy Agents Med Chem; 2012; 11(1):20-36. PubMed ID: 22934745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, Synthesis, Biological Evaluation, and Computational Studies of Novel Ureidopropanamides as Formyl Peptide Receptor 2 (FPR2) Agonists to Target the Resolution of Inflammation in Central Nervous System Disorders.
    Mastromarino M; Favia M; Schepetkin IA; Kirpotina LN; Trojan E; Niso M; Carrieri A; Leśkiewicz M; Regulska M; Darida M; Rossignolo F; Fontana S; Quinn MT; Basta-Kaim A; Leopoldo M; Lacivita E
    J Med Chem; 2022 Mar; 65(6):5004-5028. PubMed ID: 35257581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular biology for formyl peptide receptors in human diseases.
    Li Y; Ye D
    J Mol Med (Berl); 2013 Jul; 91(7):781-9. PubMed ID: 23404331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of inflammation by members of the formyl-peptide receptor family.
    Chen K; Bao Z; Gong W; Tang P; Yoshimura T; Wang JM
    J Autoimmun; 2017 Dec; 85():64-77. PubMed ID: 28689639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.